{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:15:14Z","timestamp":1783484114242,"version":"3.55.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009060","name":"Sidaction","doi-asserted-by":"publisher","award":["N\/Ref 19-2-AEQ-12566"],"award-info":[{"award-number":["N\/Ref 19-2-AEQ-12566"]}],"id":[{"id":"10.13039\/100009060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009060","name":"Sidaction","doi-asserted-by":"publisher","award":["AAP31-2-FJC-12895"],"award-info":[{"award-number":["AAP31-2-FJC-12895"]}],"id":[{"id":"10.13039\/100009060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mucosalimmunology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mucosal Immunology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.mucimm.2026.03.006","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T11:12:35Z","timestamp":1775560355000},"page":"100332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cannabidiol prevents mucosal HIV-1 transmission by targeting Langerhans cells, dendritic cells, macrophages and T-cells"],"prefix":"10.1016","volume":"19","author":[{"given":"Caio C\u00e9sar","family":"Barbosa Bomfim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"G\u00e9nin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jammy","family":"Mariotton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Matias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Cota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Barry Delongchamps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Zerbib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Bomsel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4430-7744","authenticated-orcid":false,"given":"Yonatan","family":"Ganor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mucimm.2026.03.006_b0005","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/mi.2010.32","article-title":"Within 1 h, HIV-1 uses viral synapses to enter efficiently the inner, but not outer, foreskin mucosa and engages Langerhans-T cell conjugates","volume":"3","author":"Ganor","year":"2010","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.mucimm.2026.03.006_b0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002100","article-title":"HIV-1 efficient entry in inner foreskin is mediated by elevated CCL5\/RANTES that recruits T cells and fuels conjugate formation with Langerhans cells","volume":"7","author":"Zhou","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.mucimm.2026.03.006_b0015","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/mi.2017.23","article-title":"The HIV-1 viral synapse signals human foreskin keratinocytes to secrete thymic stromal lymphopoietin facilitating HIV-1 foreskin entry","volume":"11","author":"Zhou","year":"2018","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.mucimm.2026.03.006_b0020","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.immuni.2007.01.007","article-title":"Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1","volume":"26","author":"Hladik","year":"2007","journal-title":"Immunity."},{"key":"10.1016\/j.mucimm.2026.03.006_b0025","doi-asserted-by":"crossref","first-page":"13443","DOI":"10.1128\/JVI.05615-11","article-title":"Vaginal langerhans cells nonproductively transporting HIV-1 mediate infection of T cells","volume":"85","author":"Ballweber","year":"2011","journal-title":"J Virol."},{"key":"10.1016\/j.mucimm.2026.03.006_b0030","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1038\/s41467-019-10697-w","article-title":"Identification of HIV transmitting CD11c(+) human epidermal dendritic cells","volume":"10","author":"Bertram","year":"2019","journal-title":"Nat Commun."},{"key":"10.1016\/j.mucimm.2026.03.006_b0035","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.4049\/jimmunol.1400630","article-title":"Inhibition of two temporal phases of HIV-1 transfer from primary Langerhans cells to T cells: the role of langerin","volume":"193","author":"Nasr","year":"2014","journal-title":"J Immunol."},{"key":"10.1016\/j.mucimm.2026.03.006_b0040","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1038\/s41467-021-22375-x","article-title":"Human anogenital monocyte-derived dendritic cells and langerin+cDC2 are major HIV target cells","volume":"12","author":"Rhodes","year":"2021","journal-title":"Nat Commun."},{"key":"10.1016\/j.mucimm.2026.03.006_b0045","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1182\/blood-2003-09-3129","article-title":"Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells","volume":"103","author":"Turville","year":"2004","journal-title":"Blood."},{"key":"10.1016\/j.mucimm.2026.03.006_b0050","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41564-018-0335-z","article-title":"HIV-1 reservoirs in urethral macrophages of patients under suppressive antiretroviral therapy","volume":"4","author":"Ganor","year":"2019","journal-title":"Nat Microbiol."},{"key":"10.1016\/j.mucimm.2026.03.006_b0055","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/mi.2012.116","article-title":"The adult penile urethra is a novel entry site for HIV-1 that preferentially targets resident urethral macrophages","volume":"6","author":"Ganor","year":"2013","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.mucimm.2026.03.006_b0060","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1128\/JVI.01796-08","article-title":"Macrophages in vaginal but not intestinal mucosa are monocyte-like and permissive to human immunodeficiency virus type 1 infection","volume":"83","author":"Shen","year":"2009","journal-title":"J Virol."},{"key":"10.1016\/j.mucimm.2026.03.006_b0065","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41577-019-0247-z","article-title":"Neuroimmune circuits in inter-organ communication","volume":"20","author":"Huh","year":"2020","journal-title":"Nat Rev Immunol."},{"key":"10.1016\/j.mucimm.2026.03.006_b0070","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1152\/physrev.00059.2021","article-title":"CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond","volume":"103","author":"Russo","year":"2023","journal-title":"Physiol Rev."},{"key":"10.1016\/j.mucimm.2026.03.006_b0075","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1084\/jem.20122349","article-title":"Calcitonin gene-related peptide inhibits Langerhans cell-mediated HIV-1 transmission","volume":"210","author":"Ganor","year":"2013","journal-title":"J Exp Med."},{"key":"10.1016\/j.mucimm.2026.03.006_b0080","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/apha.12366","article-title":"Calcitonin gene-related peptide inhibits human immunodeficiency type 1 transmission by Langerhans cells via an autocrine\/paracrine feedback mechanism","volume":"213","author":"Ganor","year":"2015","journal-title":"Acta Physiol (Oxf)."},{"key":"10.1016\/j.mucimm.2026.03.006_b0085","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01205-17","article-title":"Calcitonin gene-related peptide induces HIV-1 proteasomal degradation in mucosal langerhans cells","volume":"91","author":"Bomsel","year":"2017","journal-title":"J Virol."},{"key":"10.1016\/j.mucimm.2026.03.006_b0090","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1089\/aid.2018.0210","article-title":"Short communication: decreased plasma calcitonin gene-related peptide as a novel biomarker for HIV-1 disease progression","volume":"35","author":"Bomsel","year":"2019","journal-title":"AIDS Res Hum Retroviruses."},{"key":"10.1016\/j.mucimm.2026.03.006_b0095","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.785072","article-title":"Native CGRP neuropeptide and its stable analogue SAX, but not CGRP peptide fragments, inhibit mucosal HIV-1 transmission","volume":"12","author":"Mariotton","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.mucimm.2026.03.006_b0100","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/s41385-022-00521-y","article-title":"CGRP inhibits human langerhans cells infection with HSV by differentially modulating specific HSV-1 and HSV-2 entry mechanisms","volume":"15","author":"Cohen","year":"2022","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.mucimm.2026.03.006_b0105","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2302509120","article-title":"TRPV1 activation in human Langerhans cells and T cells inhibits mucosal HIV-1 infection via CGRP-dependent and independent mechanisms","volume":"120","author":"Mariotton","year":"2023","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.mucimm.2026.03.006_b0110","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/164_2018_145","article-title":"Pathways of CGRP release from primary sensory neurons","volume":"255","author":"De Logu","year":"2019","journal-title":"Handb Exp Pharmacol."},{"key":"10.1016\/j.mucimm.2026.03.006_b0115","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1124\/pr.113.008268","article-title":"Transient receptor potential channels as drug targets: from the science of basic research to the art of medicine","volume":"66","author":"Nilius","year":"2014","journal-title":"Pharmacol Rev."},{"key":"10.1016\/j.mucimm.2026.03.006_b0120","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1097\/j.pain.0000000000002268","article-title":"Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies","volume":"162","author":"Finn","year":"2021","journal-title":"Pain."},{"key":"10.1016\/j.mucimm.2026.03.006_b0125","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","article-title":"Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide","volume":"134","author":"Bisogno","year":"2001","journal-title":"Br J Pharmacol."},{"key":"10.1016\/j.mucimm.2026.03.006_b0130","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/bcpt.13710","article-title":"A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD)","volume":"130","author":"Peng","year":"2022","journal-title":"Basic Clin Pharmacol Toxicol."},{"key":"10.1016\/j.mucimm.2026.03.006_b0135","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/pr.110.003004","article-title":"International union of basic and clinical pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB(1) and CB(2)","volume":"62","author":"Pertwee","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.mucimm.2026.03.006_b0140","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.drudis.2016.08.005","article-title":"Targeting the endocannabinoid system: future therapeutic strategies","volume":"22","author":"Aizpurua-Olaizola","year":"2017","journal-title":"Drug Discov Today."},{"key":"10.1016\/j.mucimm.2026.03.006_b0145","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nri1602","article-title":"Cannabinoid-based drugs as anti-inflammatory therapeutics","volume":"5","author":"Klein","year":"2005","journal-title":"Nat Rev Immunol."},{"key":"10.1016\/j.mucimm.2026.03.006_b0150","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1097\/QAD.0000000000002345","article-title":"Cannabinoids and inflammation: implications for people living with HIV","volume":"33","author":"Costiniuk","year":"2019","journal-title":"Aids."},{"key":"10.1016\/j.mucimm.2026.03.006_b0155","doi-asserted-by":"crossref","DOI":"10.3390\/cells12141811","article-title":"Effects of oral cannabinoids on systemic inflammation and viral reservoir markers in people with HIV on antiretroviral therapy: results of the CTN PT028 pilot clinical trial","volume":"12","author":"Mboumba Bouassa","year":"2023","journal-title":"Cells."},{"key":"10.1016\/j.mucimm.2026.03.006_b0160","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.3389\/fmicb.2015.01452","article-title":"Alcohol and cannabinoids differentially affect HIV infection and function of human monocyte-derived dendritic cells (MDDC)","volume":"6","author":"Agudelo","year":"2015","journal-title":"Front Microbiol."},{"key":"10.1016\/j.mucimm.2026.03.006_b0165","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jneuroim.2003.10.026","article-title":"Cannabinoids and morphine differentially affect HIV-1 expression in CD4(+) lymphocyte and microglial cell cultures","volume":"147","author":"Peterson","year":"2004","journal-title":"J Neuroimmunol."},{"key":"10.1016\/j.mucimm.2026.03.006_b0170","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1189\/jlb.1012523","article-title":"Attenuation of HIV-1 replication in macrophages by cannabinoid receptor 2 agonists","volume":"93","author":"Ramirez","year":"2013","journal-title":"J Leukoc Biol."},{"key":"10.1016\/j.mucimm.2026.03.006_b0175","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s11481-014-9527-3","article-title":"\u0394(9)-Tetrahydrocannabinol treatment during human monocyte differentiation reduces macrophage susceptibility to HIV-1 infection","volume":"9","author":"Williams","year":"2014","journal-title":"J Neuroimmune Pharmacol."},{"key":"10.1016\/j.mucimm.2026.03.006_b0180","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1084\/jem.187.6.961","article-title":"Transforming growth factor beta1, in the presence of granulocyte\/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells","volume":"187","author":"Geissmann","year":"1998","journal-title":"J Exp Med."},{"key":"10.1016\/j.mucimm.2026.03.006_b0185","doi-asserted-by":"crossref","DOI":"10.3390\/biom13020383","article-title":"Applied clinical tandem mass spectrometry-based quantification methods for lipid-derived biomarkers, steroids and cannabinoids: fit-for-purpose validation methods","volume":"13","author":"Matias","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.mucimm.2026.03.006_b0190","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.2174\/138161206777947425","article-title":"Cannabinoids, immune system and cytokine network","volume":"12","author":"Massi","year":"2006","journal-title":"Curr Pharm Des."},{"key":"10.1016\/j.mucimm.2026.03.006_b0195","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11481-012-9430-8","article-title":"Differential expression of intracellular and extracellular CB(2) cannabinoid receptor protein by human peripheral blood leukocytes","volume":"8","author":"Castaneda","year":"2013","journal-title":"J Neuroimmune Pharmacol."},{"key":"10.1016\/j.mucimm.2026.03.006_b0200","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11481-015-9587-z","article-title":"Exposure to Delta9-tetrahydrocannabinol impairs the differentiation of human monocyte-derived dendritic cells and their capacity for T cell activation","volume":"10","author":"Roth","year":"2015","journal-title":"J Neuroimmune Pharmacol."},{"key":"10.1016\/j.mucimm.2026.03.006_b0205","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/039463201002300103","article-title":"Detailed characterisation of CB2 receptor protein expression in peripheral blood immune cells from healthy human volunteers using flow cytometry","volume":"23","author":"Graham","year":"2010","journal-title":"Int J Immunopathol Pharmacol."},{"key":"10.1016\/j.mucimm.2026.03.006_b0210","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.pharmthera.2012.12.004","article-title":"The role of CB1 in immune modulation by cannabinoids","volume":"137","author":"Kaplan","year":"2013","journal-title":"Pharmacol Ther."},{"key":"10.1016\/j.mucimm.2026.03.006_b0215","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1046\/j.1432-1033.2002.03078.x","article-title":"Presence and regulation of the endocannabinoid system in human dendritic cells","volume":"269","author":"Matias","year":"2002","journal-title":"Eur J Biochem."},{"key":"10.1016\/j.mucimm.2026.03.006_b0220","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1021\/bi500632a","article-title":"Differential activation of intracellular versus plasmalemmal CB2 cannabinoid receptors","volume":"53","author":"Brailoiu","year":"2014","journal-title":"Biochemistry."},{"key":"10.1016\/j.mucimm.2026.03.006_b0225","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/bjp.2008.324","article-title":"'Entourage' effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors","volume":"155","author":"Ho","year":"2008","journal-title":"Br J Pharmacol."},{"key":"10.1016\/j.mucimm.2026.03.006_b0230","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/eji.201546181","article-title":"Production of endocannabinoids by activated Tcells and Bcells modulates inflammation associated with delayed-type hypersensitivity","volume":"46","author":"Sido","year":"2016","journal-title":"Eur J Immunol."},{"key":"10.1016\/j.mucimm.2026.03.006_b0235","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1073\/pnas.1118167109","article-title":"Excitability of prefrontal cortical pyramidal neurons is modulated by activation of intracellular type-2 cannabinoid receptors","volume":"109","author":"den Boon","year":"2012","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.mucimm.2026.03.006_b0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033961","article-title":"Cannabinoid receptor 2-mediated attenuation of CXCR4-tropic HIV infection in primary CD4+ T cells","volume":"7","author":"Costantino","year":"2012","journal-title":"PLoS One."},{"key":"10.1016\/j.mucimm.2026.03.006_b0245","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.4049\/jimmunol.175.6.3990","article-title":"Mechanisms of HIV-1 inhibition by the lipid mediator N-arachidonoyldopamine","volume":"175","author":"Sancho","year":"2005","journal-title":"J Immunol."},{"key":"10.1016\/j.mucimm.2026.03.006_b0250","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.926696","article-title":"Cannabidiol modulates expression of type I IFN response genes and HIV infection in macrophages","volume":"13","author":"Tomer","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.mucimm.2026.03.006_b0255","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41598-021-03896-3","article-title":"Cannabinoid receptor type 2 agonist JWH-133 decreases cathepsin B secretion and neurotoxicity from HIV-infected macrophages","volume":"12","author":"Rosario-Rodriguez","year":"2022","journal-title":"Sci Rep."},{"key":"10.1016\/j.mucimm.2026.03.006_b0260","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.celrep.2018.04.028","article-title":"Live imaging of HIV-1 transfer across T cell virological synapse to epithelial cells that promotes stromal macrophage infection","volume":"23","author":"Real","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.mucimm.2026.03.006_b0265","doi-asserted-by":"crossref","DOI":"10.3390\/ph17121644","article-title":"Research and clinical practice involving the use of cannabis products, with emphasis on cannabidiol: a narrative review","volume":"17","author":"Simei","year":"2024","journal-title":"Pharmaceuticals (Basel)."},{"key":"10.1016\/j.mucimm.2026.03.006_b0270","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae492","article-title":"Limited impact of cannabidiol on health-related quality of life of people with long-term controlled HIV: a double-blind, randomized, controlled trial","volume":"11","author":"Barre","year":"2024","journal-title":"Open Forum Infect Dis."},{"key":"10.1016\/j.mucimm.2026.03.006_b0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/mi.2015.28","article-title":"Identification of preferential CD4+ T-cell targets for HIV infection in the cervix","volume":"9","author":"Joag","year":"2016","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.mucimm.2026.03.006_b0280","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.70001","article-title":"The science at HIVR4P 2024: the era of choice in biomedical HIV prevention","volume":"28","author":"Grinsztejn","year":"2025","journal-title":"J Int AIDS Soc."},{"key":"10.1016\/j.mucimm.2026.03.006_b0285","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1007\/s12325-020-01295-0","article-title":"Barriers to the wider use of pre-exposure prophylaxis in the united states: a narrative review","volume":"37","author":"Mayer","year":"2020","journal-title":"Adv Ther."},{"key":"10.1016\/j.mucimm.2026.03.006_b0290","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.15585\/mmwr.mm7347a3","article-title":"Progress toward UNAIDS global HIV pre-exposure prophylaxis targets: CDC-supported oral pre-exposure prophylaxis - 37 countries, 2017 horizontal line 2023","volume":"73","author":"Peck","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep."}],"container-title":["Mucosal Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021926000309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021926000309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T03:37:59Z","timestamp":1783481879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933021926000309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1933021926000309"],"URL":"https:\/\/doi.org\/10.1016\/j.mucimm.2026.03.006","relation":{"has-preprint":[{"id-type":"doi","id":"10.64898\/2026.01.07.697949","asserted-by":"object"}]},"ISSN":["1933-0219"],"issn-type":[{"value":"1933-0219","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabidiol prevents mucosal HIV-1 transmission by targeting Langerhans cells, dendritic cells, macrophages and T-cells","name":"articletitle","label":"Article Title"},{"value":"Mucosal Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mucimm.2026.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of Society for Mucosal Immunology.","name":"copyright","label":"Copyright"}],"article-number":"100332"}}